WS02-3-2 Predicting intravenous antibiotic usage with cardiopulmonary exercise testing in cystic fibrosis

dc.contributor.author	Wooldridge, DJ
dc.contributor.author	Tomlinson, OW
dc.contributor.author	Bland, CL
dc.contributor.author	Oades, PJ
dc.contributor.author	Sheldon, CD
dc.contributor.author	Withers, NJ
dc.contributor.author	Williams, CA
dc.date.accessioned	2019-11-21T16:09:54Z
dc.date.issued	2019-05-27
dc.identifier.citation	Vol. 18, p. S4	en_GB
dc.identifier.doi	10.1016/s1569-1993(19)30126-2
dc.identifier.uri	http://hdl.handle.net/10871/39700
dc.language.iso	en	en_GB
dc.publisher	Elsevier BV	en_GB
dc.rights.embargoreason	Under embargo until 27 May 2019 in compliance with publisher policy.	en_GB
dc.rights	© 2019. This version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/	en_GB
dc.title	WS02-3-2 Predicting intravenous antibiotic usage with cardiopulmonary exercise testing in cystic fibrosis	en_GB
dc.type	Article	en_GB
dc.date.available	2019-11-21T16:09:54Z
dc.identifier.issn	1569-1993
dc.description	This is the author accepted manuscript. The final version is available from the publisher via the DOI in this record	en_GB
dc.identifier.journal	Journal of Cystic Fibrosis	en_GB
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/	en_GB
dcterms.dateAccepted	2019-05-27
rioxxterms.version	AM	en_GB
rioxxterms.licenseref.startdate	2019-05-27
rioxxterms.type	Journal Article/Review	en_GB
refterms.dateFCD	2019-11-21T16:08:03Z
refterms.versionFCD	AM
refterms.panel	C	en_GB